← Back to Search
Silica-based Nanoparticles Are Efficient Delivery Systems For Temoporfin.
Ingrid Brezániová, K. Záruba, J. Kralova, Alla Sinica, H. Adámková, P. Ulbrich, P. Poučková, M. Hrubý, P. Štěpánek, V. Král
Published 2018 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
BACKGROUND Drug targeting using functionalized nanoparticles to advance their transport to the dedicated site became a new standard in novel anticancer methods Anticancer photodynamic therapy also takes benefit from using nanoparticles by means of increasing targeting efficiency and decreased side effect. With this in mind, the silica-based nanoparticles, as drug delivery systems for the second-generation photosensitizer 5,10,15,20-tetrakis(m-hydroxyphenyl) chlorin (temoporfin) were developed. METHODS In order to determine the stability and therapeutic performance of the selected nanomaterials in physiological fluids, their physicochemical properties (i.e. size, polydispersity, zeta potential) were measured by dynamic light scattering technique and the diameter and the morphology of the individual particles were visualized by a transmission electron microscopy. Their efficacy was compared with commercial temoporfin formulation in terms of in vitro phototoxicity in 4T1 (murine mammary carcinoma) and of in vivo anticancer effect in Nu/Nu mice bearing MDA-MB-231 tumors. RESULTS AND CONCLUSIONS The two types of silica nanoparticles, porous and non-porous and with different surface chemical modification, were involved and critically compared within the study. Their efficacy was successfully demonstrated and was shown to be superior in comparison with commercial temoporfin formulation in terms of in vitro phototoxicity and cellular uptake as well as in terms of in vivo anticancer effect on human breast cancer model. Temoporfin-loaded silica nanoparticles also passed through the blood-brain barrier showing potential for the treatment of brain metastases.
This paper references
Nanoparticles in photodynamic therapy.
S. S. Lucky (2015)
Controlled growth of monodisperse silica spheres in the micron size range
W. Stoeber (1968)
Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy.
Ingrid Brezániová (2016)
Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
M. Wacker (2010)
In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy.
Matija Rojnik (2012)
Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling.
S. Banfi (2006)
mTHPC-based photodynamic therapy induction of autophagy and apoptosis in cultured cells in relation to mitochondria and endoplasmic reticulum stress.
Aurélie François (2011)
Preparation of Silica Nanoparticles Loaded with Nootropics and Their In Vivo Permeation through Blood-Brain Barrier
J. Jampílek (2015)
Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.
Xu Wu (2014)
Novel Porphyrin Conjugates with a Potent Photodynamic Antitumor Effect: Differential Efficacy of Mono- and Bis-β-cyclodextrin Derivatives In Vitro and In Vivo
J. Kralova (2006)
Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer †,‡
M. Senge (2011)
The Embedding of Meta-tetra(Hydroxyphenyl)-Chlorin into Silica Nanoparticle Platforms for Photodynamic Therapy and Their Singlet Oxygen Production and pH-dependent Optical Properties¶
F. Yan (2003)
Vibrational modes in amorphous silicon dioxide
M. K. Gunde (2000)
Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma
Victoria Monge-Fuentes (2014)
Mesoporous silica nanoparticles: A multifunctional nano therapeutic system.
W. X. Mai (2013)
Photosensitizer doped colloidal mesoporous silica nanoparticles for three-photon photodynamic therapy
Dongyu Li (2015)
Transport and localisation of m-THPC in vitro.
D. Kessel (1999)
Unique Biological Degradation Behavior of Stöber Mesoporous Silica Nanoparticles from Their Interiors to Their Exteriors.
Guotao Chen (2015)
mTHPC--a drug on its way from second to third generation photosensitizer?
M. Senge (2012)
Cell-Based in Vitro Blood–Brain Barrier Model Can Rapidly Evaluate Nanoparticles’ Brain Permeability in Association with Particle Size and Surface Modification
Sanshiro Hanada (2014)
New photosensitizers for photodynamic therapy.
H. Abrahamse (2016)
A real-time ratiometric method for the determination of molecular oxygen inside living cells using sol-gel-based spherical optical nanosensors with applications to rat C6 glioma.
H. Xu (2001)
Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer.
T. Ohulchanskyy (2007)
Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol)
V. Cauda (2010)
Chemical modification of temoporfin--a second generation photosensitizer activated using upconverting nanoparticles for singlet oxygen generation.
Q. Yu (2014)
R: A language and environment for statistical computing.
R. Team (2014)
Controlling silica nanoparticle properties for biomedical applications through surface modification
S. Legrand (2008)
Resonance Raman spectra and normal-coordinate analysis of reduced porphyrins. 2. Copper(II) tetraphenylchlorin and copper(II) tetraphenylbacteriochlorin
R. J. Donohoe (1989)
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
I. Slowing (2008)
In vitro Studies of Functionalized Mesoporous Silica Nanoparticles for Photodynamic Therapy
H. Tu (2009)
Fine structure of 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC): a 1H, 13C and 15N NMR study
R. Bonnett (1994)
Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos
F. Sharif (2012)
Near infrared Raman spectroscopic mapping of native brain tissue and intracranial tumors.
C. Krafft (2005)
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
J. Kreuter (2004)
Raman spectroscopy at different excitation wavelengths (1064, 785 and 532 nm) as a tool for diagnosis of colon cancer
Alla Synytsya (2014)
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.
I. Roy (2003)
Combination of two chromophores: synthesis and PDT application of porphyrin-pentamethinium conjugate.
T. Bříza (2012)
In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier.
D. Liu (2014)
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
J. Lu (2007)
Spectroscopic and molecular modeling of the binding of meso-tetrakis(4-hydroxyphenyl)porphyrin to human serum albumin
Wenting An (2009)
Mesoporous silica nanoparticles for drug delivery and biosensing applications
I. Slowing (2007)
The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins.
Chiara Compagnin (2009)
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
S. O'Gorman (2016)
Binding of temoporfin to the lipoprotein fractions of human serum.
A. Michael-Titus (1995)
A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling.
T. Ghafourian (2007)
Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
J. Lee (2011)
Resonance Raman spectra and normal-coordinate analysis of reduced porphyrins. 1. Zinc(II) tetraphenylporphyrin anion
M. Atamian (1989)
Photodynamic therapy of cancer: An update
P. Agostinis (2011)
Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Hao Xu (2003)
Investigation of Foscan interactions with plasma proteins.
S. Sasnouski (2005)
REGULARIZED POSITIVE EXPONENTIAL SUM (REPES) PROGRAM : A WAY OF INVERTING LAPLACE TRANSFORM DATA OBTAINED BY DYNAMIC LIGHT SCATTERING
J. Jakeš (1995)
Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
F. Tang (2012)
Glycol porphyrin derivatives as potent photodynamic inducers of apoptosis in tumor cells.
J. Kralova (2008)
Silica nanoparticles: preparation, characterization and in vitro/in vivo biodistribution studies.
B. Tamba (2015)
Colloidal suspensions of functionalized mesoporous silica nanoparticles.
Johannes Kobler (2008)
This paper is referenced by
Mesoporous silica loaded caffeine inhibits inflammatory markers in lipopolysaccharide-activated rat macrophage cells
M. Niranjan Babu (2018)
Synthesis of Controlled-Size Silica Nanoparticles from Sodium Metasilicate and the Effect of the Addition of PEG in the Size Distribution
C. Chapa-González (2018)
Photodynamic therapy activity of new porphyrin-xylan-coated silica nanoparticles in a human colorectal cancer in vivo model
Ludovic Bretin (2019)
Supplementary Table 1. Recent research publications using passive targeting technology(s) in targeting brain metastases of breast cancer
Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies.
I. Yakavets (2019)
Photodynamic Therapy Activity of New Porphyrin-Xylan-Coated Silica Nanoparticles in Human Colorectal Cancer
Ludovic Bretin (2019)
Porphyrin-xylan-coated silica nanoparticles for anticancer photodynamic therapy.
Soukaina Bouramtane (2019)
Evaluation of polyvinylpyrrolidone and block copolymer micelle encapsulation of serine chlorin e6 and chlorin e4 on their reactivity towards albumin and transferrin and their cell uptake.
I. Gjuroski (2019)